Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
JBLU heads into its October 27 earnings print as one of the most heavily shorted names in the airline sector, with the stock down 13% over the past month and analysts cutting targets across the board.
Short sellers have built an unusually large position in JetBlue. At 26.6% of free float, short interest is one of the highest readings in the US market, and it has crept higher over the past month, up roughly 2.7%. The position is not a recent build but a persistent, high-conviction bet: the 30-day FINRA settlement figure of 96 million shares confirms the scale. Days to cover, at 5.1 based on average volume, means unwinding the position is not a one-session exercise. Yet the borrow market tells a less dramatic story: cost to borrow is just 0.49%, low in absolute terms despite rising 37% week-on-week, and availability is wide at 248% of short interest. There is plenty of room to initiate or add to shorts without a squeeze, which is probably why none has materialised despite the stock falling to $4.01.
Options positioning is broadly neutral rather than aggressively bearish. The put/call ratio is 1.01, almost exactly in line with its 20-day average of 0.99 and only fractionally above the midpoint of its 52-week range. Options traders are not piling into downside protection the way a heavily shorted stock sometimes invites. That calm is itself a signal: with 20 days to the print, the absence of a put-buying surge suggests the market is not pricing in an imminent negative catalyst.
The Street, however, has been systematically trimming its expectations. Every analyst action over the past six weeks has been a target reduction, and the moves are not small. Barclays cut from $7.00 to $5.00 in September. Citigroup, which upgraded the rating from Sell to Neutral, simultaneously cut its target from $5.30 to $4.50. Susquehanna this week lowered its target from $6.00 to $4.00, matching UBS's existing Sell-rated target. The consensus now sits at Hold with a mean target of $4.65, barely 16% above the current price of $4.01. Of 14 rated analysts, 10 are at Hold and 4 at Sell. There are no Buy ratings. The 30-day EPS momentum factor score of 96 is a notable outlier: it ranks in the 96th percentile of the universe, meaning near-term estimate revisions have been moving fast. Given the trajectory of target cuts, the direction of those revisions is clearly downward. The short score of 63.5 ranks in the 10th percentile on a short-score basis, reinforcing the bearish positioning picture.
Two significant ownership stories add context. Galkin Vladimir holds a 10% stake filed under Schedule 13G, with the position unchanged across three filings since April 2026. Icahn Partners, the highest-profile activist on the register with a Schedule 13D, has trimmed its position from 5.55% to 3.32% as last disclosed in August, a reduction that crossed the 5% reporting threshold on the way down. As is standard with 13D/G filings, these stakes are as-last-disclosed; a holder who drops below 5% may not file again. The Icahn stake reduction removes a known catalyst-seeker from the shareholder base, at least at previously reported levels. BlackRock, by contrast, has been building: its institutional holding reached 13.1% as of September 30, adding nearly 6 million shares in the most recent reported period.
JetBlue's last earnings release, in late July, produced a 5.3% jump on the day and an 18% gain over the following five sessions. That move came in the context of a higher stock price and, presumably, a different set of expectations. The stock has since given back most of those gains. Going into October 27, the question is whether the combination of maximum analyst pessimism, a deeply held short position, and a major passive buyer adding shares represents a floor, or whether the carrier's operational and financial trajectory justifies the persistent bearish consensus. Wikipedia traffic for JBLU is running well below its own 90-day average, with a z-score of minus 1.7, suggesting retail attention has faded considerably.
What to watch next: whether Citigroup's upgrade-with-a-cut and the BlackRock accumulation attract other buyers into the October 27 print, or whether continued target reductions from the remaining Hold-rated analysts push the consensus target below the current price for the first time.
See the live data behind this article on ORTEX.
Open JBLU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
